BioRestorative Therapies (BRTX) Competitors $1.54 +0.02 (+1.32%) (As of 12/24/2024 05:19 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends BRTX vs. ENZ, CCM, TOI, PMD, MRAI, ATIP, KDLY, MGRX, OTRK, and OPGNShould you be buying BioRestorative Therapies stock or one of its competitors? The main competitors of BioRestorative Therapies include Enzo Biochem (ENZ), Concord Medical Services (CCM), Oncology Institute (TOI), Psychemedics (PMD), Marpai (MRAI), ATI Physical Therapy (ATIP), Kindly MD (KDLY), Mangoceuticals (MGRX), Ontrak (OTRK), and OpGen (OPGN). These companies are all part of the "healthcare" industry. BioRestorative Therapies vs. Enzo Biochem Concord Medical Services Oncology Institute Psychemedics Marpai ATI Physical Therapy Kindly MD Mangoceuticals Ontrak OpGen BioRestorative Therapies (NASDAQ:BRTX) and Enzo Biochem (NYSE:ENZ) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, community ranking, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation. Do analysts recommend BRTX or ENZ? BioRestorative Therapies presently has a consensus target price of $18.00, suggesting a potential upside of 1,068.83%. Given BioRestorative Therapies' stronger consensus rating and higher probable upside, equities analysts clearly believe BioRestorative Therapies is more favorable than Enzo Biochem.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioRestorative Therapies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Enzo Biochem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has higher valuation and earnings, BRTX or ENZ? BioRestorative Therapies has higher earnings, but lower revenue than Enzo Biochem. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioRestorative Therapies$377K28.27-$14.41M-$1.53-1.01Enzo Biochem$30.31M1.25-$26.08MN/AN/A Does the media favor BRTX or ENZ? In the previous week, Enzo Biochem had 2 more articles in the media than BioRestorative Therapies. MarketBeat recorded 2 mentions for Enzo Biochem and 0 mentions for BioRestorative Therapies. BioRestorative Therapies' average media sentiment score of 0.00 beat Enzo Biochem's score of -0.07 indicating that BioRestorative Therapies is being referred to more favorably in the media. Company Overall Sentiment BioRestorative Therapies Neutral Enzo Biochem Neutral Is BRTX or ENZ more profitable? Enzo Biochem has a net margin of -81.73% compared to BioRestorative Therapies' net margin of -2,697.08%. Enzo Biochem's return on equity of -11.84% beat BioRestorative Therapies' return on equity.Company Net Margins Return on Equity Return on Assets BioRestorative Therapies-2,697.08% -98.49% -75.23% Enzo Biochem -81.73%-11.84%-8.31% Does the MarketBeat Community believe in BRTX or ENZ? Enzo Biochem received 210 more outperform votes than BioRestorative Therapies when rated by MarketBeat users. However, 100.00% of users gave BioRestorative Therapies an outperform vote while only 54.64% of users gave Enzo Biochem an outperform vote. CompanyUnderperformOutperformBioRestorative TherapiesOutperform Votes2100.00% Underperform VotesNo VotesEnzo BiochemOutperform Votes21254.64% Underperform Votes17645.36% Which has more volatility and risk, BRTX or ENZ? BioRestorative Therapies has a beta of 62.59, suggesting that its share price is 6,159% more volatile than the S&P 500. Comparatively, Enzo Biochem has a beta of 0.75, suggesting that its share price is 25% less volatile than the S&P 500. Do insiders and institutionals hold more shares of BRTX or ENZ? 69.4% of BioRestorative Therapies shares are owned by institutional investors. Comparatively, 36.9% of Enzo Biochem shares are owned by institutional investors. 25.5% of BioRestorative Therapies shares are owned by company insiders. Comparatively, 11.4% of Enzo Biochem shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryBioRestorative Therapies beats Enzo Biochem on 10 of the 16 factors compared between the two stocks. Ad WealthPressYour chance to get on the next “60-Second Trade”Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here! Get BioRestorative Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for BRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BRTX vs. The Competition Export to ExcelMetricBioRestorative Therapieshealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.66M$1.92B$5.23B$9.28BDividend YieldN/A7.08%5.12%4.28%P/E Ratio-1.0115.7787.7017.30Price / Sales28.273.161,167.68119.60Price / CashN/A9.7743.2337.83Price / Book0.633.094.834.93Net Income-$14.41M$69.56M$120.55M$225.42M7 Day Performance9.22%4.08%2.86%4.14%1 Month Performance1.99%-7.86%19.71%1.15%1 Year Performance-11.89%-24.60%30.57%16.99% BioRestorative Therapies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BRTXBioRestorative Therapies3.5092 of 5 stars$1.54+1.3%$18.00+1,068.8%-11.9%$10.66M$377,000.00-1.017Positive NewsENZEnzo Biochem0.8401 of 5 stars$0.75-1.7%N/A-48.1%$39.17M$30.31M0.00520Analyst ForecastCCMConcord Medical Services0.4119 of 5 stars$4.71+6.6%N/A-57.8%$20.45M$471.70M0.00970TOIOncology Institute2.7127 of 5 stars$0.210.0%$2.50+1,090.5%-87.3%$15.87M$378.93M-0.27660PMDPsychemedics1.252 of 5 stars$2.67-1.8%N/A-5.7%$15.73M$22.10M-5.24140Positive NewsGap DownHigh Trading VolumeMRAIMarpaiN/A$1.07+8.9%$6.00+460.7%-41.5%$14.70M$34.87M-0.41150ATIPATI Physical TherapyN/A$2.45+0.8%N/A-62.1%$10.81M$741.86M-0.135,600Gap UpKDLYKindly MDN/A$1.12flatN/AN/A$6.69M$2.88M0.00N/AMGRXMangoceuticals1.2147 of 5 stars$2.47-0.4%N/A-96.1%$6.14M$755,000.00-0.433Positive NewsGap DownOTRKOntrak2.687 of 5 stars$1.42-1.7%$45.00+3,080.2%-77.0%$5.97M$11.24M-0.13250Positive NewsOPGNOpGenN/A$0.71-2.0%N/A-86.1%$5.93M$2.67M0.00100Gap Down Related Companies and Tools Related Companies Enzo Biochem Competitors Concord Medical Services Competitors Oncology Institute Competitors Psychemedics Competitors Marpai Competitors ATI Physical Therapy Competitors Kindly MD Competitors Mangoceuticals Competitors Ontrak Competitors OpGen Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BRTX) was last updated on 12/25/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioRestorative Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioRestorative Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BRTX Stock Alerts